Vaccine News and Research

Latest Vaccine News and Research

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

10 Aug 2022
A broad sarbecovirus-neutralizing antibody cocktail

A broad sarbecovirus-neutralizing antibody cocktail

9 Aug 2022
Next-generation monoclonal antibody prevents malaria

Next-generation monoclonal antibody prevents malaria

9 Aug 2022
Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

9 Aug 2022
MIT researchers develop an easy-to-use test to predict Covid-19 immunity

MIT researchers develop an easy-to-use test to predict Covid-19 immunity

9 Aug 2022
Lower risk of MIS-C during Omicron wave

Lower risk of MIS-C during Omicron wave

9 Aug 2022
B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

9 Aug 2022
New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

9 Aug 2022
Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

9 Aug 2022
The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

9 Aug 2022
How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

9 Aug 2022
Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

9 Aug 2022
COVID-19 vaccination increases antibodies in breast milk significantly

COVID-19 vaccination increases antibodies in breast milk significantly

8 Aug 2022
Sperm not affected nine months after COVID-19 mRNA vaccination

Sperm not affected nine months after COVID-19 mRNA vaccination

8 Aug 2022
Study tests equine polyclonal antibodies against SARS-CoV-2 variants

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

8 Aug 2022
What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

8 Aug 2022
What is the vaccine effectiveness of BNT162b2 against Omicron in five to 11-year-olds?

What is the vaccine effectiveness of BNT162b2 against Omicron in five to 11-year-olds?

8 Aug 2022
Assessing immunization capacity of vaccine platforms with DNA origami harboring SARS-CoV-2 receptor binding domain

Assessing immunization capacity of vaccine platforms with DNA origami harboring SARS-CoV-2 receptor binding domain

8 Aug 2022
BCG vaccine produces a "trained immunity response" which lasts more than a year

BCG vaccine produces a "trained immunity response" which lasts more than a year

8 Aug 2022
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

7 Aug 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback